Fate Therapeutics (FATE) Return on Sales (2012 - 2026)
Fate Therapeutics (FATE) posted Return on Sales of 1.14% for Q1 2026, down 378.99% on a QoQ basis from 0.24% in Q4 2025, and down 11.0% year-over-year from 1.28% in Q1 2025.
Fate Therapeutics (FATE) Return on Sales (2012 - 2026) Analysis & Trends
Fate Therapeutics' Return on Sales history runs 14 years deep, the most recent figure standing at 1.14% for Q1 2026.
- Quarterly Return on Sales fell 11.0% year-over-year to 1.14% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.48% (up 26.0% YoY) and the FY2025 annual result came in at 0.79%, down 38.0% from the prior year.
- Return on Sales was 1.14% for Q1 2026 at Fate Therapeutics, down from 0.24% in the prior quarter.
- Across five years, Return on Sales topped out at 0.02% in Q1 2023 and bottomed at 2.26% in Q4 2024.
- A 5-year average of 0.69% and a median of 0.43% in 2025 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2023 — Return on Sales sank 211 bps — and 2025, when it surged 202 bps.
- Fate Therapeutics' Return on Sales stood at 0.08% in 2022, then slumped by 2619 bps to 2.19% in 2023, then retreated by 3 bps to 2.26% in 2024, then soared by 89 bps to 0.24% in 2025, then sank by 379 bps to 1.14% in 2026.
- Business Quant data shows FATE's Return on Sales at 1.14% in Q1 2026, 0.24% in Q4 2025, and 0.43% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 0.00% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Fate Therapeutics | 288.82 Mn | 288.82 Mn | - | -1.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.14% |
| Dec 31, 2025 | -0.24% |
| Sep 30, 2025 | -0.43% |
| Jun 30, 2025 | -0.24% |
| Mar 31, 2025 | -1.03% |
| Dec 31, 2024 | -2.26% |
| Sep 30, 2024 | -0.65% |
| Jun 30, 2024 | -0.29% |
| Mar 31, 2024 | -0.54% |
| Dec 31, 2023 | -2.19% |
| Sep 30, 2023 | -1.10% |
| Jun 30, 2023 | -1.31% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.08% |
| Sep 30, 2022 | -0.10% |
| Jun 30, 2022 | -0.14% |
| Mar 31, 2022 | -0.05% |
| Dec 31, 2021 | -0.17% |
| Sep 30, 2021 | -0.17% |
| Jun 30, 2021 | -0.09% |